https://www.selleckchem.com/pr....oducts/deferoxamine-
001). After adjusting for age and gender status, the risk of reaching the composite endpoint was higher in the group with comorbidity than in that without comorbidity (hazard ratio [HR] 3.04, 95% confidence interval [CI] 1.40-6.6. HR values for patients with one, two, and three or more comorbidities were 1.61 (95% CI 0.44-5.91), 3.44 (95% CI 1.31-9.08), and 6.90 (95% CI 2.69-17.69), respectively. COVID-19 patients with comorbidities had worse clinical outcomes as compared with those without any comorbidity. The higher th
Like
Comment
Share
